Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Dexamethasone × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 220 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Recurrence 31 Neoplasms 20 Burkitt Lymphoma 20 Neoplasms, Plasma Cell 16 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12 Immunoglobulin Light-chain Amyloidosis 11 Neoplasm Metastasis 10 Leukemia 10 Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Prostatic Neoplasms 7 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myeloid, Acute 7 Lymphoma 6 Leukemia, Biphenotypic, Acute 6 Lymphoma, Non-Hodgkin 5 Triple Negative Breast Neoplasms 4 Smoldering Multiple Myeloma 4 Neoplasm, Residual 4 Lymphoma, Mantle-Cell 4 Hodgkin Disease 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Waldenstrom Macroglobulinemia 3 Vomiting 3 Rectal Neoplasms 3 Plasmacytoma 3

Interventions

Cisplatin 15 Pemetrexed 12 pembrolizumab 8 Nivolumab 8 Carboplatin 7 Ipilimumab 5 Cyclophosphamide 5 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Gemcitabine 3 Drug Therapy 3 tremelimumab 2 fludarabine 2 durvalumab 2 atezolizumab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Photochemotherapy 2 Methotrexate 2 Interleukin-2 2 Chemotherapy, Adjuvant 2 sargramostim 1 olaparib 1 niraparib 1 nintedanib 1 methoxyamine 1 lenvatinib 1 enzalutamide 1 decitabine and cedazuridine drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡